Literature DB >> 520395

The pharmacokinetics of misonidazole in the dog.

R A White, P Workman, L S Freedman, L N Owen, N M Bleehen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 520395     DOI： 10.1016/0014-2964(79)90249-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.

Authors:  P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Renal elimination of the hypoxic cell radiosensitizer misonidazole in Wistar rats: influence of some drugs on its excretion.

Authors:  G Akel; P Canal; G Soula
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Jul-Sep       Impact factor: 2.441

3.  Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.

Authors:  F Y Lee; P Workman
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

4.  The penetration of misonidazole into a mature structural cartilage.

Authors:  A J Langler; R D Bugden; P Gibson
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

5.  Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.

Authors:  R A White; P Workman
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.